A Pilot Randomized Control Trial Evaluating the Feasibility of a 12-Week Mediterranean Diet Intervention Without Caloric Restriction in Women with Polycystic Ovary Syndrome

<b>Background/Objectives</b>: Women with Polycystic Ovary Syndrome (PCOS) often report difficulties adhering to dietary interventions due to a combination of physiological and psychological barriers. Therefore, this study explores the feasibility of a Mediterranean diet (MedDiet) intervention as an effective and acceptable dietary approach for managing PCOS. <b>Methods</b>: Women with PCOS and a BMI ≥ 25 kg/m<sup>2</sup>, aged 18-45 years were randomized to an ad libitum MedDiet or Healthy Eating (HE) diet (control). The 12-week intervention incorporated fortnightly, personalized dietary consultations and tailored resources. Primary outcomes were measures of feasibility, including recruitment metrics, data collection methods, and intervention adherence. Acceptability was examined using semi-structured interviews and surveys for those randomized to the MedDiet. <b>Results</b>: Study promotion resulted in <i>n =</i> 380 interested individuals; a total of <i>n</i> = 26 were randomized to either a MedDiet (<i>n</i> = 12) or HE (<i>n</i> = 14) group. Data collection was mostly appropriate as demonstrated by the collection of 100% of anthropometric and biochemical data; however, only 69% of the 4-day food records were returned. Participants reported the intervention was acceptable, and adherence was enhanced through individualized counselling and the provision of practical resources. At week 12, adherence was significantly greater in the MedDiet group compared to HE (8.1 ± 2.4 vs. 4.6 ± 1.0; <i>p</i> = 0.002). Adherence significantly improved from baseline to week 12 in both groups (MedDiet: 3.67 ± 1.32; 8.11 ± 2.37; <i>p</i> ≤ 0.001; HE: 3.57 ± 1.27; 4.57 ± 0.98; <i>p</i> = 0.02). <b>Conclusions</b>: We showed that a 12-week pilot MedDiet intervention is feasible and acceptable for women with PCOS and a BMI ≥ 25 kg/m<sup>2</sup>. Future investigation warrants a larger, adequately powered study which addresses challenges to recruitment, attrition and collection of dietary intake data.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-08-18
DOI
https://doi.org/10.3390/jcm14165842
Citations
1
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Pilot Randomized Control Trial Evaluating the Feasibility of a 12-Week Mediterranean Diet Intervention Without Caloric Restriction in Women with Polycystic Ovary Syndrome

Evangeline Mantzioris, Lisa Moran, Nicole Scannell, Stephanie Cowan et al.
1 citations
Journal of Clinical Medicine
Ovarian function and disorders
1.70
article

A Pilot Randomized Control Trial Evaluating the Feasibility of a 12-Week Mediterranean Diet Intervention Without Caloric Restriction in Women with Polycystic Ovary Syndrome

Evangeline Mantzioris, Lisa Moran, Nicole Scannell, Stephanie Cowan, Anthony M. Villani
article en
1 citations

Abstract

<b>Background/Objectives</b>: Women with Polycystic Ovary Syndrome (PCOS) often report difficulties adhering to dietary interventions due to a combination of physiological and psychological barriers. Therefore, this study explores the feasibility of a Mediterranean diet (MedDiet) intervention as an effective and acceptable dietary approach for managing PCOS. <b>Methods</b>: Women with PCOS and a BMI ≥ 25 kg/m<sup>2</sup>, aged 18-45 years were randomized to an ad libitum MedDiet or Healthy Eating (HE) diet (control). The 12-week intervention incorporated fortnightly, personalized dietary consultations and tailored resources. Primary outcomes were measures of feasibility, including recruitment metrics, data collection methods, and intervention adherence. Acceptability was examined using semi-structured interviews and surveys for those randomized to the MedDiet. <b>Results</b>: Study promotion resulted in <i>n =</i> 380 interested individuals; a total of <i>n</i> = 26 were randomized to either a MedDiet (<i>n</i> = 12) or HE (<i>n</i> = 14) group. Data collection was mostly appropriate as demonstrated by the collection of 100% of anthropometric and biochemical data; however, only 69% of the 4-day food records were returned. Participants reported the intervention was acceptable, and adherence was enhanced through individualized counselling and the provision of practical resources. At week 12, adherence was significantly greater in the MedDiet group compared to HE (8.1 ± 2.4 vs. 4.6 ± 1.0; <i>p</i> = 0.002). Adherence significantly improved from baseline to week 12 in both groups (MedDiet: 3.67 ± 1.32; 8.11 ± 2.37; <i>p</i> ≤ 0.001; HE: 3.57 ± 1.27; 4.57 ± 0.98; <i>p</i> = 0.02). <b>Conclusions</b>: We showed that a 12-week pilot MedDiet intervention is feasible and acceptable for women with PCOS and a BMI ≥ 25 kg/m<sup>2</sup>. Future investigation warrants a larger, adequately powered study which addresses challenges to recruitment, attrition and collection of dietary intake data.

Journal of Clinical MedicineVol. 14(16)
University of South Australia (AU), University of the Sunshine Coast (AU), Monash University (AU)
Monash University, University of South Australia, University of the Sunshine Coast, Medical Research Council, National Health and Medical Research Council
Openalex Percentile: Top 14%
Ovarian function and disorders
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.